Trending Topic

3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

The expansion of HIV treatment access during the past two decades, particularly in low- and middle-income countries, stands as a significant accomplishment in the field of public health.1 Currently, there are an estimated 30 million people on antiretroviral treatment for HIV globally, of whom approximately 70% reside in Africa.2 Despite advancements in the provision of antiretroviral therapy […]

Carlos Chaccour, ISNTD d3 2021: Ivermectin for COVID-19

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Mar 22nd 2021

It was a delight to be able to speak with Dr Carlos Chaccour (University of Barcelona, Barcelona, Spain) about the controversy currently surrounding the use of ivermectin for the treatment of COVID-19.

His presentation entitled Ivermectin and COVID: what’s going on?  was presented at the ISNTD d3 2021 Virtual Congress, 24-25 February.

Questions:

  1. Could you give us a brief overview of the controversy surrounding the use of ivermectin for the treatment of COVID-19? (0:49)
  2. What evidence has been generated to date to help support the case for and against the drug’s use? (3:53)
  3. What further evidence is emerging on the efficacy of ivermectin in this indication? (6:36)

Disclosures: Dr Carlos Chaccour has nothing to disclose in relation to this video interview.

Support: Interview and filming supported by Touch Medical Media

Filmed in coverage of ISNTD d3 2021 Virtual Conference.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

This Functionality is for
Members Only

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

Close Popup